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Incontinuationofourshort-term pilotstudies reported earlier, results oncertaintoxicity biomarkersinvolunteers who continued
to take the potentized Arsenicum album 200C till 2 years are presented. Out of some 130 “verum”-fed volunteers of pilot study, 96
continued to takethe remedy till 6months,65 till 1year and15 amongthem continued till 2years. They provided samplesof their
urine and blood at 6 months, 1 year and ﬁnally at 2 years. None out of 17 who received “placebo” turned up for providing blood
or urine at these longer intervals. Standard methodologies were used for determination of arsenic content in blood and urine,
and for measurement of toxicity biomarkers like acid and alkaline phosphatases, alanine and aspartate amino transferases, lipid
peroxidation and reduced glutathione and anti-nuclear antibody titers. Most of the volunteers reported status quo maintained
after the improvement they achieved within the ﬁrst 3 months of homeopathic treatment, in respect of their general health and
spirit,andappetite andsleep. A fewwith skinsymptomsandburning sensation,however, improvedfurther. Thiswassupported by
the data oftoxicity biomarkers,levels of all of which remained fairly within normalrange. Therefore, administration of Arsenicum
album 200C considerably ameliorates symptoms of arsenic toxicity on a long-term basis, and can be recommended for interim
use, particularly in high risk remote villages lacking modern medical and arsenic free drinking water facilities. Similar studies by
others are encouraged.
1.Introduction
In continuation of our short-term (2-3 months) studies [1–
4],inthiscommunicationweintendtoreportdataonseveral
toxicity biomarkers recorded periodically up to 2 years in
a group of people living in high-risk arsenic contaminated
villages of Ghetugachhi and Dakshinpanchpota, District
Nadia, West Bengal, India and regularly taking Arsenicum
album 200C, one dose daily for 6 consecutive days every
month. The primary objective of the study was to ascertain
whether the volunteers regularly taking the remedy could get
further beneﬁtsorat leastcouldsustain the beneﬁtsobtained
till 3 months of taking Arsenicum album 30C. We chose to
publish this brief report on the follow-up study of cases
reported earlier with thehope that the resultsmay encourage
other workers to replicate the study and to send out the
message for the beneﬁt of a large number of people living
in high-risk arsenic contaminated areas lacking any proper
medical facilities, particularly in poor countries.
2.Methods
This study was ethically cleared by the Ethical Committee
of the University of Kalyani, and with due permission from
the Government of West Bengal. “Informed consents” of the
volunteers were also obtained prior to beginning this human
trial.
2.1. The Subjects. After the pilot studies were carried out







Figure 1: Patient showing typical skin symptoms on soles before drug (BD) and after 2 months and 1 year of administration (after drug,
AD) of Arsenicum album.
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on a total number of 130 odd subjects distributed in
two arsenic contaminated villages, namely, Ghetugachi and
Dakshinpanchpota, 96 of them turned up to give their
blood and urine samples at 6 months and 65 of them
turned up at 1 year. Apart from some socio-political
problems occasionally ﬁnding outburst in these villages,
one of the other main reasons for the drop-outs could be
that the anemic and weak subjects were afraid of giving
even small amount of blood for such studies as they felt














Figure 3: Patient showingtypical skin symptoms on lips BD and after 2 months and 1 year of administration (AD) of Arsenicum album.4 Evidence-Based Complementary and Alternative Medicine
Table 2: Statistical analyses through one-way ANOVA of As content in urine and blood between before and after administration of verum
groups at 0.05 and 0.001% levels
Sum of squares df Mean square F Sig.
As in urine 0.05%
Between groups 606 344.931 3 202 114.977 7.577 0.000
Within groups 7 335 673.459 275 26 675.176
Total 7 942 018.390 278
As in urine 0.001%
Between groups 606 344.931 3 202 114.977 7.577 0.000
Within groups 7 335 673.459 275 26 675.176
Total 7 942 018.390 278
As in Blood 0.05%
Between groups 224 260.499 3 74 753.500 12.834 0.000
Within groups 1 724 044.813 296 5 824.476
Total 1 948 305.312 299
As in Blood 0.001%
Between groups 224 260.499 3 74 753.500 12.834 0.000
Within groups 1 724 044.813 296 5824.476







Figure 4: Patient showing typical skin symptoms on soles BD and after 2 months and 1 year of administration (AD) of Arsenicum album.Evidence-Based Complementary and Alternative Medicine 5
Table 3: Statistical analyses through one-way ANOVA of AcP, AIkP, AST, ALT, LPO and GSH between before and after administration of
verum groups at 0.05 and 0.001% levels
Sum of squares df Mean square F Sig.
Acp 0.05%
Between groups 608.154 3 202.718 32.805 0.000
Within groups 1841.459 298 6.179
Total 2449.613 301
Acp 0.001%
Between groups 608.154 3 202.718 32.805 0.000
Within groups 1841.459 298 6.179
Total 2449.613 301
AlkP 0.05%
Between groups 268.420 3 89.473 54.706 0.000
Within groups 487.386 298 1.636
Total 755.806 301
AlkP 0.001%
Between groups 270.590 3 90.197 55.974 0.000
Within groups 480.201 298 1.611
Total 750.791 301
AST 0.05%
Between groups 90.025 3 30.008 25.388 0.000
Within groups 345.143 292 1.182
Total 435.168 295
AST 0.001%
Between groups 25.800 3 8.600 23.974 0.000
Within groups 105.103 293 .359
Total 130.903 296
ALT 0.05%
Between groups 90.025 3 30.008 25.388 0.000
Within groups 345.143 292 1.182
Total 435.168 295
ALT 0.001%
Between groups 90.025 3 30.008 25.388 0.000
Within groups 345.143 292 1.182
Total 435.168 295
LPO 0.05%
Between groups 5.703 3 1.901 79.314 0.000
Within groups 6.951 290 2.397
Total 12.654 293
LPO 0.001%
Between groups 5.686 3 1.895 78.813 0.000
Within groups 6.950 289 2.405
Total 12.636 292
GSH 0.05%
Between groups 3833.749 3 1277.916 27.127 0.000
Within groups 13802.670 293 47.108
Total 17636.419 296
GSH 0.001%
Between groups 3833.749 3 1277.916 27.127 0.000
Within groups 13 802.670 293 47.108







Figure 5: Patient showing hyper-pigmentation on hands BD and after 2 months and 1 year of administration(AD) of Arsenicum album.
normal life and they thought they could no longer be
able to replenish blood because of the bad eﬀect of the
poison. Furthermore, many of them were poor daily wage
earners who did not like to lose even a day’s work as
laborers in the ﬁeld. Once we thought of paying their daily
wage in compensation, but seniors among locals advised
against that because that could give them the impression
that we have vested interest in getting their “precious”
blood! Therefore, we had to subsequently abandon the
idea. However, out of 65 persons, who continued to take
the remedy subsequently, only 15 turned up at 2 years.
On the other hand, all 17 subjects who received “placebo”
did not turn up at all afterwards for giving their blood
and urine samples. This we thought was not practicable
either to keep these victims on “placebo” for such a long
trial. Therefore, the study was limited to the “verum”-fed
subjects alone, and a reasonably large number of the subjects
actually participated till 1 year. These subjects were advised
to take six to eight globules (No. 20) soaked with Arsenicum
album 200C (manufactured by Boiron, France) once daily
for six consecutive days in empty stomach every month.
Their blood samples were processed for analysis of six
toxicity biomarkers, namely, AcP, AlkP, LPO, GSH, AST and
ALT and anti-nuclear antibodies (ANA) with the standard
techniques described in our earlier paper [1]. The patients
who presented themselves were medically checked up (for
blood pressure, pulse rate, possible enlargement of spleen,
liver, etc.)bytwoqualiﬁedhomeopathicdoctorsinourteam.
They were also asked about their general physical conditions
like appetite, bowel clearance, sleep, urination, muscle or
joint pains, skin itching, and so forth. on a subjective basis,
and whether any of these were, in their opinion, perceivably
ameliorated.
Blood and urine samples of 26 volunteers (23 males and
3females)fromthevillage,Padumbasan (about160kmaway
from district Nadia), under Tamluk subdivision of Purba
Medinipur district, West Bengal, India, known to be free of
ground water arsenic (and also conﬁrmed by us from water
samples of diﬀerent tube wells in the village) were tested
and conﬁrmed to have no detectable arsenic in them. Their
blood samples, however, were also analyzed for diﬀerent
other parameters of study like AcP, AlkP, ALT, AST, LPO,
GSH and ANA titer, which were used as negative controls
(i.e., of subjects not intoxicated with arsenic). Most of the
volunteers came from the same socioeconomic background
and had generally good health, albeit with minor gastric
problem, but two of them complained of occasional muscle

















































































































































































































































































BD = before drug
AD = after drug
(g)
Figure 6: (a) Arsenic content in urine and blood of subjects fed Arsenicum album 200C; ∗∗P < .01, ∗∗∗P < .001. (b) AcP activity in subjects
fed Arsenicum album 200C againstnegative control; ∗∗P < .01, ∗∗∗∗P < .001. (c) AlkP activity in subjects fed Arsenicum album 200C against
negative control; ∗∗P < .01, ∗∗∗P < .001. (d) AST activity in subjects fed Arsenicum album 200C against negative control; ∗∗P < .01, ∗∗∗P
< .001. (e) ALT activity in subjects fed Arsenicum album 200C against negative control; ∗∗P < .01, ∗∗∗P < .001. (f) LPO in subjects fed
Arsenicum album 200C against negative control; ∗∗P < .01, ∗∗∗P < .001. (g) GSH content in subjects fed Arsenicum album 200C against
negative control; ∗∗P < .01, ∗∗∗P < .001.
2.2. Collection of Blood Samples. Volunteers of diﬀerent age
groupsand sex were toldnot to takeany food before drawing
blood in the morning. Blood was drawn from the superﬁcial
vein around the forearm region of the volunteers of diﬀerent
age groups and sex (who were told not to take any food
before drawing the blood) by the routine procedure using
sterile disposable syringe and needle. Blood was collected in
vials containingEDTA(anticoagulant)andtheotherwithout8 Evidence-Based Complementary and Alternative Medicine
EDTA. In the laboratory, blood was centrifuged at 3000g for
10 min and serum was obtained from blood without EDTA.
Blood with EDTA was used for determination of arsenic
content.
2.3. Toxicity Biomarker Assays. All standard protocols for
quantitative estimation of the biomarkers were followed: for
example, Walter and Schutt [5]f o rA c Pa n dA l k P ,B u e g ea n d
Aust [6] for LPO, Bergmeyer and Brent [7]f o rA S Ta n d
ALT and Ellman [8] for GSH. Total protein was measured
according to the method of Lowry et al. (1951) [9].
2.4. Arsenic Estimation from Urine and Blood. First void
urine samples was collected from each volunteer in separate
sterilized pre-acid washed bottles. Blood samples were taken
in two blood-collecting vials—one containing EDTA for As
analysis and the other without EDTA for serum analysis.
Immediately after collection, the samples—both urine and
a part of blood were stored at −20◦C until further processing
for As estimation in the laboratory. The As content in urine
andbloodwasdeterminedbytheproceduredescribedearlier
[1].
2.5. Determination of ANA Titer. A small part of blood
serum was taken for ANA test by using an ANA Detect
kit (ANA ORG 600; ORGENTEC Diagnostika GmbH,
Germany) with the aid of an ELISA Reader (ELDEX 3.8,
USA).
2.6. Statistical Analysis. The signiﬁcance of diﬀerence
betweendataofthediﬀerentintervalsofdrugadministration
was conducted by Student’st-test [10]a n do n e - w a yA N O V A
(SPSS 10.0 Software, both at 0.05 and 0.001% levels).
Uniformity was maintained in scoring data of both “before
and after administration of the verum” groups of patient.
T h es t a t i s t i c a lc o m p a r i s o n sw e r em a d eb e t w e e nt h ed a t a
takenbeforeadministration ofArsenicum album 200Cand to
that of verum administered groups after diﬀerent intervals.
Furthermore, we performed Bonferroni and Tukey test (data
not shown) for multiple comparison between these two
treatments (before and after verum administration), so that
the drop-out factor did not aﬀect the analysis.
3.Resultsand Discussion
3.1. General Health Condition and Appetite. The subjects in
general who turned up were in fairly good health having
normal appetite, sleep and relatively free of typical arsenic
symptoms of burning sensation and pain in muscles and
joints. Many of those having skin symptoms also showed
further improvement in their skin symptoms (Figures 1, 2,
3, 4,a n d5). Incidentally, this kind of improvement in skin
symptoms achieved by this homeopathic remedy had not
been reported to be achieved by any orthodox medicine
earlier. Furthermore, they also felt much better in respect of
the burning sensation under their sole, palm and eyes. They
also felt energetic and could work more in ﬁelds. Those who
had vertigo also were better than before.
3.2.ArsenicContentinBloodand Urine. Thearseniccontents
in blood and urine have steadily decreased till 2 years
(Figure 6(a)).
3.3. Toxicity Biomarkers. The data on diﬀerent toxicity
biomarkers have been presented in Figures 6(b)–6(g).E x c e p t
for ALT(Figure 6(e))thetoxicitymarkersrevealedmaintain-
ing a steady low level in case of AcP, AlkP, AST, LPO and
an increase in GSH content depicting relatively good level of
liver function and indicating low amount of oxidative stress.
These people, who complained of various stomach and liver
ailments before their treatment, also experienced much relief
of their problem. Although the ALT level was found to be
slightly at higher level, it was not much beyond the upper
threshold limit.
3.4. ANA Titer. In this group of 130 volunteers, as many
as 37 males and 19 females tested ANA positive before
administration of Arsenicum album,w h i l eA N At i t e r so f
eight males and three females were in the borderline of
positivity [2, 4]. On administration of the Arsenicum album
200C, all the ANA-positive cases tested negative for ANA
titer till 1 year except for seven males and four females
who again tested positive and one male and three females
were in the borderline (Table 1). Thus about 18% of the
subjects who turned ANA-negative by the administration
of the homeopathic drug only again turned ANA-positive
after a year or so while the overwhelming majority (82%)
still remained ANA-negative. Those who remained ANA-
negative, also experienced much less pain in the muscles and
joints which they complained before administration of the
homeopathic remedy.
3.5. Statistical Signiﬁcance. Results of Student’s t-test and
one-way ANOVA indicating the level of signiﬁcance (∗P <
.005; ∗∗P < .01; ∗∗∗P < .001 and at 0.05 and 0.001% levels,
respectively) are given in Figures 6(a)– 6(g) and Tables 2
and 3. The results of statistical analyses through one-way
ANOVA for each parameter revealed signiﬁcance of diﬀer-
ence between the data of “before verum administration”
and “after verum administration” groups at both 0.05 and
0.001% levels.
The results of the follow-up study in “verum”-fed
subjects showed that the homeopathic remedy considerably
ameliorated symptoms of arsenicosis both in respect of
liver enzymes as well as on skin symptoms. The subjects
taking Arsenicum album 200C apparently sustained the
initial improvements for a period up to 1 year, and some
of them who turned up at 2 years were also found to
be in a much better health, signifying sustenance of the
ameliorative eﬀects of Arsenicum album for quite a long
time. Though in the absence of a suitable control group, the
observed ameliorative changes can not be strictly ascribed
to only drug eﬀect, it is emphasized that the homeopathic
drug appeared to act positively in a fairly large number
of aﬀected people, who got beneﬁts from this treatment.
The role of other factors like spontaneous amelioration, or
changes in life style, psychological eﬀect, sampling error,Evidence-Based Complementary and Alternative Medicine 9
and so forth, if any, inﬂuencing the results can only be
known if further controlled studies on a larger scale can be
carried out by other researchers or independent groups. In
countries like Bangladesh and India where medical facilities
and arsenic-free drinking water plants are not available in
the overwhelming majority of villages, the information that
homeopathic remedies can give them a better quality of life
at an aﬀordably low cost may bring some relief and cheers to
a large number of poorpeople,at least as an interim measure
till they can be oﬀered better medical facilities and adequate
network of arsenic-free drinking water. Government and
non-Government NGOs may get involved in making arsenic
victimsaware ofthebeneﬁtsthathomeopathictreatmentcan
provide to them, particularly when they simultaneously take
arsenic-free drinking water and the homeopathic remedy
under supervision of a homeopathic practitioner, so that the
beneﬁt can reach the ones who actually need it most.
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